Myung-Hwan Kim
University of Ulsan
Internal medicineRadiologySurgeryPathologyPancreatitisGallbladderAutoimmune pancreatitisEndoscopic retrograde cholangiopancreatographyEndoscopyStentPancreasBile ductPancreatic ductPancreatic cancerEndoscopic ultrasoundPercutaneousIn patientGeneral surgeryMedicineGastroenterology
707Publications
89H-index
17.2kCitations
Publications 705
Newest
Source
#1Dong Hui ChoH-Index: 8
#2Sang Soo LeeH-Index: 26
Last. Myung-Hwan KimH-Index: 89
view all 7 authors...
Source
#1Joon Hyuk Choi (DU: Dankook University)H-Index: 21
#2Dong-Wan Seo (UOU: University of Ulsan)H-Index: 40
Last. Myung-Hwan Kim (UOU: University of Ulsan)H-Index: 89
view all 7 authors...
Background Radiofrequency ablation (RFA) has been increasingly employed in experimental and clinical settings for the management of pancreatic lesions. This study aimed to assess the safety and efficacy of endoscopic ultrasound (EUS)-guided RFA for benign solid pancreatic tumors. Methods In a single-center, prospective study, 10 patients with benign solid pancreatic tumors underwent EUS-RFA. After the RFA electrode had been inserted into the pancreatic mass, the radiofrequency generator was acti...
31 CitationsSource
#1Jihoon Kang (SKKU: Sungkyunkwan University)H-Index: 20
#1Jihoon Kang (SKKU: Sungkyunkwan University)H-Index: 12
Last. Baek-Yeol Ryoo (UOU: University of Ulsan)H-Index: 34
view all 19 authors...
Purpose nab-paclitaxel plus gemcitabine (AG) and FOLFIRINOX have been established as standard first-line treatment in metastatic pancreatic cancer (mPC). We performed retrospective analysis comparing the efficacies of AG and FOLFIRINOX in daily practice setting. Materials and Methods We analyzed 308 patients who presented initially as mPC and received AG (n = 149) or FOLFIRINOX (n = 159) as first-line treatment between 2013 and 2016. Primary endpoints were progression-free survival (PFS) and ove...
46 CitationsSource
#1H. LeeH-Index: 41
#1H. J. LeeH-Index: 10
Last. Su-Ryun KimH-Index: 17
view all 8 authors...
Source
Source
#1Eun-Jung KimH-Index: 29
#2Eun Chang ChoiH-Index: 51
Last. E. Yu
view all 9 authors...
Source
#1Soon Auck Hong (SCH: Soonchunhyang University)H-Index: 10
#2You Na Sung (UOU: University of Ulsan)H-Index: 2
Last. Seung-Mo Hong (UOU: University of Ulsan)H-Index: 59
view all 11 authors...
Aims Xanthogranulomatous cholecystitis (XGC), an unusual histologic variant of chronic cholecystitis, is characterized by mixed foamy histiocytic and lymphoplasmocytic infiltration and fibrosis. Radiologically, the poorly defined nodular growth pattern often leads to the misinterpretation of XGC as gallbladder cancer. In this study, we aimed to identify the relationship of XGC with IgG4-related cholecystitis, Methods and Results We re-evaluated 57 surgically resected XGCs and 104 conventional ch...
7 CitationsSource
#1Kyoungmin Lee (UOU: University of Ulsan)H-Index: 6
#2Changhoon Yoo (UOU: University of Ulsan)H-Index: 24
Last. Baek-Yeol Ryoo (UOU: University of Ulsan)H-Index: 34
view all 20 authors...
Introduction Germline BRCA mutations may have therapeutic implications as surrogate markers of DNA-damage repair status in pancreatic ductal adenocarcinoma (PDAC). We performed a prospective study to evaluate the efficiency of risk criteria based on personal or family history of breast and ovarian cancer for determining germline BRCA mutations in PDAC patients with Asian ethnicity. Methods Between November 2015 and May 2016, we screened consecutive PDAC patients with locally advanced unresectabl...
2 CitationsSource
#1Hyun Woo Lee (SCH: Soonchunhyang University)H-Index: 4
#2Sung-Hoon Moon (Sacred Heart Hospital)H-Index: 8
Last. Sung Koo Lee (UOU: University of Ulsan)H-Index: 69
view all 11 authors...
Background Type 1 autoimmune pancreatitis (AIP), as a pancreatic manifestation of IgG4-related disease, shows a favorable prognosis in the short term. However, disease relapse is common in long-term follow-up, despite a successful initial treatment response. This study aimed to identify the predictors of relapse and long-term outcomes in patients with type 1 AIP.
23 CitationsSource